Retour

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial

Health Health

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial

GlobeNewswire Inc. • 08/05/2024 à 23:35:00
PLUS THERAPEUTICS, Inc. Common Stock
Address: 4200 MARATHON BLVD.
Postal Code: 78756
City: AUSTIN
State: TX
Phone Number: 737.255.7194
Website: https://www.plustherapeutics.com
Status: Active
Company Info

Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focuses on the discovery, development, and delivery of complex treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS.

List Date2000-11-16
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001095981
Composite figiBBG000C1Z086
Share Class figiBBG001SFQL35
Market Cap17,799,428 USD
SIC Code3841
SIC DescriptionSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Total Employees20
Share Class Shares Outstanding4280000
Weighted Shares Outstanding7946173
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
2.245
2.28
2.24
2.165
2.225
Variance
-1.45%
1.79%
3.37%
-2.17%
3.06%
Open
2.278
2.24
2.167
2.213
2.159
Highest
2.315
2.369
2.447
2.213
2.255
Lowest
2.315
2.346
2.425
2.19
2.255
History
PeriodVarhighestlowest
1 week
3.98%
2.255
2.19
1 month
36.89%
2.16
1.64
3 month
2.56%
2.189
1.64
6 month
1.13%
2.5
1.61
1 year
-42.27%
3.91
0.9694
3 year
-93.01%
35.1
0.9694
5 year
-98.64%
165
0.9694
10 year
-98.64%
165
0.9694
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-04-20 2023-08-14 2023-10-31 UNPUB
Assets 15,638,000 14,197,000 13,278,000 UNPUB
Current Assets 13,629,000 12,364,000 11,584,000 UNPUB
Current Liabilities 12,796,000 11,399,000 10,538,000 UNPUB
Equity 2,676,000 2,662,000 2,622,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 2,676,000 2,662,000 2,622,000 UNPUB
Liabilities 12,962,000 11,535,000 10,656,000 UNPUB
Liabilities And Equity 15,638,000 14,197,000 13,278,000 UNPUB
Noncurrent Assets 2,009,000 1,833,000 1,694,000 UNPUB
Noncurrent Liabilities 166,000 136,000 118,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-04-20 2023-08-14 2023-10-31 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -5,397,000 -1,828,000 111,000 UNPUB
Net Cash Flow, Continuing -5,397,000 -1,828,000 111,000 UNPUB
Net Cash Flow From Financing Activities 493,000 961,000 2,520,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 493,000 961,000 2,520,000 UNPUB
Net Cash Flow From Investing Activities -97,000 -11,000 -10,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -97,000 -11,000 -10,000 UNPUB
Net Cash Flow From Operating Activities -5,793,000 -2,778,000 -2,399,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -5,793,000 -2,778,000 -2,399,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-04-20 2023-08-14 2023-10-31 UNPUB
Comprehensive Income/Loss -4,805,000 -1,482,000 -3,219,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -4,805,000 -1,482,000 -3,219,000 UNPUB
Other Comprehensive Income/Loss 0 0 0 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-04-20 2023-08-14 2023-10-31 UNPUB
Basic Earnings Per Share 0 -1 -1 UNPUB
Benefits Costs and Expenses 5,311,000 3,336,000 4,459,000 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 5,226,000 3,344,000 4,491,000 UNPUB
Diluted Earnings Per Share 0 -1 -1 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,805,000 -1,482,000 -3,219,000 UNPUB
Income/Loss From Continuing Operations Before Tax -4,805,000 -1,482,000 -3,219,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 134,000 112,000 87,000 UNPUB
Net Income/Loss -4,805,000 -1,482,000 -3,219,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -4,805,000 -1,482,000 -3,219,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -4,805,000 -1,482,000 -3,219,000 UNPUB
Operating Expenses 5,226,000 3,344,000 4,491,000 UNPUB
Operating Income/Loss -4,720,000 -1,490,000 -3,251,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 506,000 1,854,000 1,240,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-04-21 2022-07-21 2022-10-20 2023-02-23
Assets 24,516,000 21,271,000 23,104,000 23,867,000
Current Assets 22,104,000 18,889,000 20,879,000 21,817,000
Current Liabilities 4,921,000 6,971,000 7,420,000 11,852,000
Equity 14,642,000 9,679,000 11,404,000 6,445,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 14,642,000 9,679,000 11,404,000 6,445,000
Liabilities 9,874,000 11,592,000 11,700,000 17,422,000
Liabilities And Equity 24,516,000 21,271,000 23,104,000 23,867,000
Noncurrent Assets 2,412,000 2,382,000 2,225,000 2,050,000
Noncurrent Liabilities 0 0 4,280,000 5,570,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-04-21 2022-07-21 2022-10-20 2023-02-23
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 2,839,000 -3,149,000 2,176,000 -280,000
Net Cash Flow, Continuing 2,839,000 -3,149,000 2,176,000 -280,000
Net Cash Flow From Financing Activities 7,292,000 -371,000 6,431,000 13,451,000
Net Cash Flow From Financing Activities, Continuing 7,292,000 -371,000 6,431,000 13,451,000
Net Cash Flow From Investing Activities -577,000 -138,000 -33,000 -759,000
Net Cash Flow From Investing Activities, Continuing -577,000 -138,000 -33,000 -759,000
Net Cash Flow From Operating Activities -3,876,000 -2,640,000 -4,222,000 -12,972,000
Net Cash Flow From Operating Activities, Continuing -3,876,000 -2,640,000 -4,222,000 -12,972,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-04-21 2022-07-21 2022-10-20 2023-02-23
Comprehensive Income/Loss -4,116,000 -5,282,000 -5,219,000 -20,275,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,116,000 -5,282,000 -5,219,000 -20,275,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-04-21 2022-07-21 2022-10-20 2023-02-23
Basic Earnings Per Share 0 0 0 -1
Benefits Costs and Expenses UNPUB UNPUB 5,292,000 20,499,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB 5,167,000 19,936,000
Diluted Earnings Per Share 0 0 0 -1
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,116,000 -5,282,000 -5,219,000 -20,275,000
Income/Loss From Continuing Operations Before Tax -4,116,000 -5,282,000 -5,219,000 -20,275,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating 198,000 181,000 173,000 711,000
Net Income/Loss -4,116,000 -5,282,000 -5,219,000 -20,275,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,116,000 -5,282,000 -5,219,000 -20,275,000
Net Income/Loss Available To Common Stockholders, Basic -4,116,000 -5,282,000 -5,219,000 -20,275,000
Operating Expenses 3,926,000 5,120,000 5,167,000 19,936,000
Operating Income/Loss -3,926,000 -5,120,000 -5,094,000 -19,712,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 73,000 224,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-22 2021-07-22 2021-10-21 2022-02-24
Assets 18,336,000 20,834,000 24,750,000 21,981,000
Current Assets 15,446,000 18,001,000 22,097,000 19,724,000
Current Liabilities 8,315,000 8,354,000 9,488,000 5,870,000
Equity 9,513,000 11,945,000 14,755,000 10,836,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 9,513,000 11,945,000 14,755,000 10,836,000
Liabilities 8,823,000 8,889,000 9,995,000 11,145,000
Liabilities And Equity 18,336,000 20,834,000 24,750,000 21,981,000
Noncurrent Assets 2,890,000 2,833,000 2,653,000 2,257,000
Noncurrent Liabilities 0 0 507,000 5,275,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-22 2021-07-22 2021-10-21 2022-02-24
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 6,101,000 2,714,000 4,119,000 10,054,000
Net Cash Flow, Continuing 6,101,000 2,714,000 4,119,000 10,054,000
Net Cash Flow From Financing Activities 9,191,000 5,109,000 6,374,000 20,416,000
Net Cash Flow From Financing Activities, Continuing 9,191,000 5,109,000 6,374,000 20,416,000
Net Cash Flow From Investing Activities -84,000 4,000 -4,000 -82,000
Net Cash Flow From Investing Activities, Continuing -84,000 4,000 -4,000 -82,000
Net Cash Flow From Operating Activities -3,006,000 -2,399,000 -2,251,000 -10,280,000
Net Cash Flow From Operating Activities, Continuing -3,006,000 -2,399,000 -2,251,000 -10,280,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-22 2021-07-22 2021-10-21 2022-02-24
Comprehensive Income/Loss -2,720,000 -2,800,000 -3,724,000 -13,399,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,720,000 -2,800,000 -3,724,000 -13,399,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-22 2021-07-22 2021-10-21 2022-02-24
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -2,720,000 -2,800,000 -3,724,000 -13,399,000
Income/Loss From Continuing Operations Before Tax -2,720,000 -2,800,000 -3,724,000 -13,399,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating 247,000 229,000 232,000 932,000
Net Income/Loss -2,720,000 -2,800,000 -3,724,000 -13,399,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,720,000 -2,800,000 -3,724,000 -13,399,000
Net Income/Loss Available To Common Stockholders, Basic -2,720,000 -2,800,000 -3,724,000 -13,399,000
Operating Expenses 2,479,000 2,575,000 3,499,000 12,492,000
Operating Income/Loss -2,479,000 -2,575,000 -3,499,000 -12,492,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-10 2020-10-22 2021-02-22
Assets 20,967,000 13,904,000 11,653,000 12,105,000
Current Assets 17,697,000 10,793,000 8,649,000 9,175,000
Current Liabilities 14,988,000 9,773,000 8,404,000 8,539,000
Equity 85,000 3,300,000 2,621,000 3,031,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 85,000 3,300,000 2,621,000 3,031,000
Liabilities 20,882,000 10,604,000 9,032,000 9,074,000
Liabilities And Equity 20,967,000 13,904,000 11,653,000 12,105,000
Noncurrent Assets 3,270,000 3,111,000 3,004,000 2,930,000
Noncurrent Liabilities 0 0 628,000 535,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-10 2020-10-22 2021-02-22
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -1,531,000 -6,795,000 -1,640,000 -9,246,000
Net Cash Flow, Continuing -1,531,000 -6,795,000 -1,640,000 -9,246,000
Net Cash Flow From Financing Activities -18,000 -4,974,000 673,000 -319,000
Net Cash Flow From Financing Activities, Continuing -18,000 -4,974,000 673,000 -319,000
Net Cash Flow From Investing Activities -11,000 -412,000 -14,000 -493,000
Net Cash Flow From Investing Activities, Continuing -11,000 -412,000 -14,000 -493,000
Net Cash Flow From Operating Activities -1,502,000 -1,409,000 -2,299,000 -8,434,000
Net Cash Flow From Operating Activities, Continuing -1,502,000 -1,409,000 -2,299,000 -8,434,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-10 2020-10-22 2021-02-22
Comprehensive Income/Loss -1,087,000 -1,839,000 -1,728,000 -8,241,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,087,000 -1,839,000 -1,728,000 -8,241,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-10 2020-10-22 2021-02-22
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 1,205,000 2,024,000 1,728,000 8,544,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 2,559,000 2,537,000 1,396,000 9,887,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -1,087,000 -1,839,000 -1,728,000 -8,241,000
Income/Loss From Continuing Operations Before Tax -1,087,000 -1,839,000 -1,728,000 -8,241,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating 349,000 252,000 253,000 1,107,000
Net Income/Loss -1,087,000 -1,839,000 -1,728,000 -8,241,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,087,000 -1,839,000 -1,728,000 -8,241,000
Net Income/Loss Available To Common Stockholders, Basic -1,087,000 -1,839,000 -1,728,000 -8,241,000
Operating Expenses 2,559,000 2,537,000 1,396,000 9,887,000
Operating Income/Loss -2,441,000 -2,352,000 -1,396,000 -9,584,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 118,000 185,000 0 303,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2019-11-14 2020-03-30
Assets UNPUB UNPUB 25,715,000 23,229,000
Current Assets UNPUB UNPUB 22,264,000 19,825,000
Current Liabilities UNPUB UNPUB 14,427,000 14,486,000
Equity UNPUB UNPUB 160,000 1,160,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Equity Attributable To Parent UNPUB UNPUB 160,000 1,160,000
Liabilities UNPUB UNPUB 25,555,000 22,069,000
Liabilities And Equity UNPUB UNPUB 25,715,000 23,229,000
Noncurrent Assets UNPUB UNPUB 3,451,000 3,404,000
Noncurrent Liabilities UNPUB UNPUB 11,128,000 7,583,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2019-11-14 2020-03-30
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB 12,304,000 12,295,000
Net Cash Flow, Continuing UNPUB UNPUB 12,304,000 12,295,000
Net Cash Flow From Financing Activities UNPUB UNPUB 14,424,000 12,631,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 14,424,000 12,631,000
Net Cash Flow From Investing Activities UNPUB UNPUB -2,000 5,570,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB -2,000 5,570,000
Net Cash Flow From Operating Activities UNPUB UNPUB -2,118,000 -5,906,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB -2,118,000 -5,906,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2019-11-14 2020-03-30
Comprehensive Income/Loss UNPUB UNPUB 526,000 -10,887,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB 526,000 -10,887,000
Other Comprehensive Income/Loss UNPUB UNPUB 526,000 -10,887,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2019-11-14 2020-03-30
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB 4,245,000 10,281,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB 2,091,000 10,655,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB 526,000 -3,283,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB 526,000 -3,283,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB 366,000 1,855,000
Net Income/Loss UNPUB UNPUB 526,000 -10,887,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Net Income/Loss Attributable To Parent UNPUB UNPUB 526,000 -10,887,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB -28,000 -11,441,000
Operating Expenses UNPUB UNPUB 2,091,000 10,655,000
Operating Income/Loss UNPUB UNPUB 2,680,000 -3,657,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB 554,000 554,000
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB 554,000 554,000
Revenues UNPUB UNPUB 4,771,000 6,998,000
Calendar
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
News Stream
Management Directors and Officers
Plus Therapeutics Announces New Employment Inducement Grants
Plus Therapeutics Announces New Employment Inducement Grants
GlobeNewswire Inc. • 2d ago
Stocks Earnings Releases and Operating Results
Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire Inc. • 4d ago
Calendar Calendar of Events
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
GlobeNewswire Inc. • 6d ago
Health Health
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
GlobeNewswire Inc. • 1w ago
Stocks Financing Agreements
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
GlobeNewswire Inc. • 1w ago
News News
Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Revenue Estimates
Plus (PSTV) delivered earnings and revenue surprises of 10.26% and 4.21%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research • 2mo ago
Stocks Earnings Releases and Operating Results
Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Began enrollment of the 5th of an anticipated 7 planned dosing cohorts for the ReSPECT-LM Phase 1 dose escalation trial with rhenium (186Re) obisbemeda for leptomeningeal metastases (LM)
GlobeNewswire Inc. • 2mo ago
News Other News
Plus Updates Financial and Cash Guidance for 2024
Plus Receives $3.3M in grant revenue in Q4 2023
GlobeNewswire Inc. • 5mo ago
News Regulatory information
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to Rhenium (186Re) Obisbemeda for the Treatment of Breast Cancer with Leptomeningeal Metastases
AUSTIN, Texas, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to rhenium (186Re) obisbemeda for the treatment of breast cancer with leptomeningeal metastases (LM).
GlobeNewswire Inc. • 6mo ago
Stocks Changes in company's own shares
Plus Therapeutics Announces Share Repurchase Program
AUSTIN, Texas, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced that its Board of Directors has approved a share repurchase program, with authorization to repurchase up to $500,000 of the Company’s outstanding common stock. The Company intends to fund any share repurchases with available cash.
GlobeNewswire Inc. • 6mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT